ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 632,71
0,00%
Dow Jones
40 211,72
0,53%
DAX
18 590,89
-0,95%
Brent Oil
83,985
-0,42%
Bitcoin
63 767,88
-1,66%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
26/03/200913h00Business WireAllos Therapeutics to Present at the 4th Annual Citi Biotech DayNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/03/200913h06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/03/200913h00Business WireAllos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell L...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/03/200922h30Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/03/200913h00Business WireAllos Therapeutics Appoints David M. Stout to Its Board of DirectorsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/03/200921h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/03/200913h00Business WireAllos Therapeutics’ Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Bladder Cancer by the Eu...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/03/200922h00Business WireAllos Therapeutics Reports 2008 ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/02/200922h00Business WireAllos Therapeutics to Report 2008 Results on March 3, 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/02/200922h24Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/02/200922h49Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/12/200822h00Business WireAllos Therapeutics to Present at the RBC Capital Markets 2008 Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/12/200817h03Business WireAllos Therapeutics Announces Top Line Results from Pivotal Phase 2 PROPEL Trial of Pralatrexate in Patients with Relapsed or ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/12/200818h30Business WireTwo Pralatrexate Studies Presented at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/12/200814h00Business WireAllos Therapeutics to Host Analyst and Investor Briefing on Monday, December 8, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/12/200822h00Business WireU.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Follicular LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/11/200822h00Business WireU.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell LymphomaNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/11/200823h09Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/11/200815h17Business WireFour Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200823h09Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200822h00Business WireAllos Therapeutics Reports 2008 Third Quarter ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/11/200814h00Business WireAllos Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/10/200821h00Business WireFour Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/10/200813h00Business WireAllos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/10/200814h00Business WireAllos Therapeutics to Present at the JMP Healthcare Focus ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/09/200815h05Edgar (US Regulatory)Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/09/200823h06Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/09/200814h00Business WireAllos Therapeutics to Present at the 3rd Annual Citi Biotech DayNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/08/200822h00Business WireAllos Therapeutics to Present at the NewsMakers in the Biotech Industry ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/08/200822h17Edgar (US Regulatory)Allos Therapeutics Inc - Amended Annual Report (10-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

EU
AF
Air FranceKLM
EU
RNO
Renault
SPI
SP500
S&P 500
NASDAQ
AMZN
Amazon.com
FTSE
UKX
FTSE 100
COIN
ETHUSD
Ethereum
EU
VK
Vallourec
USI
USTECH100
US Tech 100
NYSE
NKE
Nike
EU
ML
Michelin
EU
ORA
Orange
EU
BEL20
Bel 20
EU
BN
Danone
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés